Giving It Our Best Shot? Human Papillomavirus and Hepatitis B Virus Immunization Among Refugees, Massachusetts, 2011-2013

Rachel Stein Berman, Laura Smock, Megan H. Bair-Merritt, Jennifer Cochran, Paul L. Geltman

Research output: Contribution to journalArticle

Abstract

INTRODUCTION: The receipt rate of hepatitis B virus vaccine among adolescents in the United States is high, while the receipt rate of human papillomavirus vaccine is low. Rates have not been closely studied among refugees, whose home countries have high rates of disease caused by these viruses.

METHODS: We examined human papillomavirus and hepatitis B virus immunization rates among 2,269 refugees aged 9 to 26 years who resettled in Massachusetts from 2011 through 2013. This was a secondary analysis of data from their medical screenings. We used binary logistic regression to assess characteristics associated with immunization and bivariate analyses to compare refugee immunization rates with those of the general US population.

RESULTS: Forty-five percent of US adolescents aged 13 to 17 years received 1 dose of human papillomavirus vaccine, compared with 68% of similarly aged refugees. Males (adjusted odds ratio [aOR], 0.62; 95% confidence interval [CI], 0.52-0.74), refugees older than 13 years (aOR, 0.74; 95% CI, 0.60-0.93), and refugees not from Sub-Saharan Africa (aOR, 0.74; 95% CI, 0.59-0.92) were less likely to receive human papillomavirus vaccine, while arrivals in 2012 through 2013 were more likely (aOR, 1.6; 95% CI, 1.3-1.9) than those arriving in 2011. Refugees older than 13 years were less likely to receive 2 doses of hepatitis B virus vaccine (aOR, 0.49; 95% CI, 0.37-0.63) than older refugees.

CONCLUSION: Specialized post-arrival health assessment may improve refugees' immunization rates.

Original languageEnglish (US)
Pages (from-to)E50
JournalPreventing chronic disease
Volume14
DOIs
StatePublished - Jun 22 2017
Externally publishedYes

Fingerprint

Refugees
Hepatitis B virus
Immunization
Papillomavirus Vaccines
Odds Ratio
Confidence Intervals
Hepatitis B Vaccines
Africa South of the Sahara
Virus Diseases
Logistic Models
Health

ASJC Scopus subject areas

  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this

Giving It Our Best Shot? Human Papillomavirus and Hepatitis B Virus Immunization Among Refugees, Massachusetts, 2011-2013. / Stein Berman, Rachel; Smock, Laura; Bair-Merritt, Megan H.; Cochran, Jennifer; Geltman, Paul L.

In: Preventing chronic disease, Vol. 14, 22.06.2017, p. E50.

Research output: Contribution to journalArticle

Stein Berman, Rachel ; Smock, Laura ; Bair-Merritt, Megan H. ; Cochran, Jennifer ; Geltman, Paul L. / Giving It Our Best Shot? Human Papillomavirus and Hepatitis B Virus Immunization Among Refugees, Massachusetts, 2011-2013. In: Preventing chronic disease. 2017 ; Vol. 14. pp. E50.
@article{9071c4e8115d436ebddffa1e42d1cffa,
title = "Giving It Our Best Shot? Human Papillomavirus and Hepatitis B Virus Immunization Among Refugees, Massachusetts, 2011-2013",
abstract = "INTRODUCTION: The receipt rate of hepatitis B virus vaccine among adolescents in the United States is high, while the receipt rate of human papillomavirus vaccine is low. Rates have not been closely studied among refugees, whose home countries have high rates of disease caused by these viruses.METHODS: We examined human papillomavirus and hepatitis B virus immunization rates among 2,269 refugees aged 9 to 26 years who resettled in Massachusetts from 2011 through 2013. This was a secondary analysis of data from their medical screenings. We used binary logistic regression to assess characteristics associated with immunization and bivariate analyses to compare refugee immunization rates with those of the general US population.RESULTS: Forty-five percent of US adolescents aged 13 to 17 years received 1 dose of human papillomavirus vaccine, compared with 68{\%} of similarly aged refugees. Males (adjusted odds ratio [aOR], 0.62; 95{\%} confidence interval [CI], 0.52-0.74), refugees older than 13 years (aOR, 0.74; 95{\%} CI, 0.60-0.93), and refugees not from Sub-Saharan Africa (aOR, 0.74; 95{\%} CI, 0.59-0.92) were less likely to receive human papillomavirus vaccine, while arrivals in 2012 through 2013 were more likely (aOR, 1.6; 95{\%} CI, 1.3-1.9) than those arriving in 2011. Refugees older than 13 years were less likely to receive 2 doses of hepatitis B virus vaccine (aOR, 0.49; 95{\%} CI, 0.37-0.63) than older refugees.CONCLUSION: Specialized post-arrival health assessment may improve refugees' immunization rates.",
author = "{Stein Berman}, Rachel and Laura Smock and Bair-Merritt, {Megan H.} and Jennifer Cochran and Geltman, {Paul L.}",
year = "2017",
month = "6",
day = "22",
doi = "10.5888/pcd14.160442",
language = "English (US)",
volume = "14",
pages = "E50",
journal = "Preventing chronic disease",
issn = "1545-1151",
publisher = "U.S. Department of Health and Human Services",

}

TY - JOUR

T1 - Giving It Our Best Shot? Human Papillomavirus and Hepatitis B Virus Immunization Among Refugees, Massachusetts, 2011-2013

AU - Stein Berman, Rachel

AU - Smock, Laura

AU - Bair-Merritt, Megan H.

AU - Cochran, Jennifer

AU - Geltman, Paul L.

PY - 2017/6/22

Y1 - 2017/6/22

N2 - INTRODUCTION: The receipt rate of hepatitis B virus vaccine among adolescents in the United States is high, while the receipt rate of human papillomavirus vaccine is low. Rates have not been closely studied among refugees, whose home countries have high rates of disease caused by these viruses.METHODS: We examined human papillomavirus and hepatitis B virus immunization rates among 2,269 refugees aged 9 to 26 years who resettled in Massachusetts from 2011 through 2013. This was a secondary analysis of data from their medical screenings. We used binary logistic regression to assess characteristics associated with immunization and bivariate analyses to compare refugee immunization rates with those of the general US population.RESULTS: Forty-five percent of US adolescents aged 13 to 17 years received 1 dose of human papillomavirus vaccine, compared with 68% of similarly aged refugees. Males (adjusted odds ratio [aOR], 0.62; 95% confidence interval [CI], 0.52-0.74), refugees older than 13 years (aOR, 0.74; 95% CI, 0.60-0.93), and refugees not from Sub-Saharan Africa (aOR, 0.74; 95% CI, 0.59-0.92) were less likely to receive human papillomavirus vaccine, while arrivals in 2012 through 2013 were more likely (aOR, 1.6; 95% CI, 1.3-1.9) than those arriving in 2011. Refugees older than 13 years were less likely to receive 2 doses of hepatitis B virus vaccine (aOR, 0.49; 95% CI, 0.37-0.63) than older refugees.CONCLUSION: Specialized post-arrival health assessment may improve refugees' immunization rates.

AB - INTRODUCTION: The receipt rate of hepatitis B virus vaccine among adolescents in the United States is high, while the receipt rate of human papillomavirus vaccine is low. Rates have not been closely studied among refugees, whose home countries have high rates of disease caused by these viruses.METHODS: We examined human papillomavirus and hepatitis B virus immunization rates among 2,269 refugees aged 9 to 26 years who resettled in Massachusetts from 2011 through 2013. This was a secondary analysis of data from their medical screenings. We used binary logistic regression to assess characteristics associated with immunization and bivariate analyses to compare refugee immunization rates with those of the general US population.RESULTS: Forty-five percent of US adolescents aged 13 to 17 years received 1 dose of human papillomavirus vaccine, compared with 68% of similarly aged refugees. Males (adjusted odds ratio [aOR], 0.62; 95% confidence interval [CI], 0.52-0.74), refugees older than 13 years (aOR, 0.74; 95% CI, 0.60-0.93), and refugees not from Sub-Saharan Africa (aOR, 0.74; 95% CI, 0.59-0.92) were less likely to receive human papillomavirus vaccine, while arrivals in 2012 through 2013 were more likely (aOR, 1.6; 95% CI, 1.3-1.9) than those arriving in 2011. Refugees older than 13 years were less likely to receive 2 doses of hepatitis B virus vaccine (aOR, 0.49; 95% CI, 0.37-0.63) than older refugees.CONCLUSION: Specialized post-arrival health assessment may improve refugees' immunization rates.

UR - http://www.scopus.com/inward/record.url?scp=85045069340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045069340&partnerID=8YFLogxK

U2 - 10.5888/pcd14.160442

DO - 10.5888/pcd14.160442

M3 - Article

C2 - 28641071

AN - SCOPUS:85045069340

VL - 14

SP - E50

JO - Preventing chronic disease

JF - Preventing chronic disease

SN - 1545-1151

ER -